Fong Donald S, Girach Aniz, Boney April
Department of Ophthalmology, Kaiser Permanente Medical Center, Pasadena, CA, USA.
Retina. 2007 Sep;27(7):816-24. doi: 10.1097/IAE.0b013e318042d32c.
To review the literature on limitations and adverse effects associated with scatter or panretinal laser photocoagulation (PRP) for diabetic retinopathy (DR).
Literature review.
Scatter laser photocoagulation is associated with moderate visual loss, some diminished visual field, reduced color vision, and reduced contrast sensitivity.
Scatter laser photocoagulation has been shown to reduce the risk of severe visual loss from proliferative DR. However, scatter treatment is associated with some decline in visual function. These effects should be studied more extensively and should be considered when comparing pharmacologic treatments for proliferative DR.
回顾关于糖尿病性视网膜病变(DR)的散在或全视网膜激光光凝(PRP)相关局限性及不良反应的文献。
文献综述。
散在激光光凝与中度视力丧失、部分视野缩小、色觉减退及对比敏感度降低有关。
散在激光光凝已被证明可降低增生性DR导致严重视力丧失的风险。然而,散在治疗会导致视觉功能有所下降。这些影响应进行更广泛的研究,并且在比较增生性DR的药物治疗时应予以考虑。